Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Audio By Carbonatix

IRVINE, Calif.--(BUSINESS WIRE)--Dec 18, 2025--

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251218869141/en/

CONTACT: Media Contact: Amy Meshulam,[email protected]

Investor Contact: Mark Wilterding,[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH OTHER SCIENCE GENERAL HEALTH RESEARCH CARDIOLOGY SCIENCE

SOURCE: Edwards Lifesciences Corporation

Copyright Business Wire 2025.

PUB: 12/18/2025 07:05 AM/DISC: 12/18/2025 07:06 AM

http://www.businesswire.com/news/home/20251218869141/en